Study on the Effects of Pulmonary Artery Stenting in Patients with d-TGA, Tetralogy of Fallot, and Truncus Arteriosus
Led by UMC Utrecht · Updated on 2025-03-30
56
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying the effects of percutaneous interventions for branch pulmonary artery PA stenosis on exercise capacity in patients with dextro transposition of the great arteries d-TGA, Tetralogy of Fallot ToF, and Truncus Arteriosus TA. This randomized controlled trial also aims to assess the impact of these interventions on right ventricular RV function and to identify early markers to improve the timing of treatment. The study responds to the need for clearer guidelines on when to perform these interventions, as current knowledge about their effects on exercise capacity and heart function is limited.
Participants are divided into two groups one undergoing percutaneous stent placement for PA stenosis and a control group receiving conservative management with potential delayed intervention. Both groups will receive standard care evaluations, including transthoracic echocardiogram TTE, cardiopulmonary exercise testing CPET, and cardiac magnetic resonance imaging CMR. The interventional group will have additional low dose dobutamine stress MRI at certain centers and RV pressure measurements during the intervention. Quality of life questionnaires will be collected at baseline and shortly after intervention or corresponding time points in controls. Long-term follow-up with TTE, CPET, and CMR will occur within 2 to 4 years.
During the study, participants will undergo examinations at baseline and approximately six months later to measure exercise capacity VO2 max, RV function, and adaptation. Assessments include imaging, exercise testing, and questionnaires to evaluate heart performance and quality of life. Researchers will compare results between groups to determine the effects of the intervention. Safety and technical success will also be monitored through pressure and gradient measurements. The total study duration includes initial assessments, intervention or observation periods, and extended follow-up to understand long-term outcomes.
CONDITIONS
Brief Title
Effects Branch PA Stenting d-TGA, ToF and TA
Research Team
H
Hans Breur, MD, PhD
R
Renée Joosen, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients diagnosed with d-TGA post ASO, Tetralogy of Fallot, or Truncus Arteriosus
8 years of age or older
Class IIa indication for percutaneous intervention for branch pulmonary artery stenosis according to guidelines
You will not qualify if you...
Persistent decreased right ventricular function below specified thresholds based on age and cardiac MRI results
Moderate or greater progressive tricuspid regurgitation
Isolated bifurcation stenosis with significant unilateral or borderline bilateral pulmonary artery stenosis
Unbalanced lung perfusion with less than 35% to one lung
Right ventricle to left ventricle pressure ratio greater than 2/3 based on echocardiography
Reduced lung perfusion or decreased exercise capacity below defined VO2 max cutoffs based on age and sex
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Baseline Assessments
Duration - Up to 4 weeks prior to intervention
Participants undergo baseline examinations including transthoracic echocardiogram, cardiopulmonary exercise testing, and cardiac MRI. For the interventional group, the baseline MRI is performed as close as possible prior to the intervention but no more than 4 weeks before.
1 to 2 visits depending on group assignment
Treatment
Duration - Single intervention visit with possible follow-up within 6 months
Participants in the interventional group receive percutaneous stenting for branch pulmonary artery stenosis. Those in the control group receive conservative management and may receive intervention after approximately 6 months if necessary.
1 intervention visit (in-person) and quality of life questionnaire 2 weeks after intervention or comparable time in control group
6 Month Follow-up Assessments
Duration - Approximately 6 months after baseline
Participants undergo follow-up examinations including echocardiogram, exercise testing, and cardiac MRI to assess effects of intervention or conservative management.
1 visit (in-person)
Long-term Follow-up
Duration - 2 to 4 years after baseline
Participants have additional assessments at 2 to 4 years to evaluate long-term effects on heart function and exercise capacity.
1 to 2 visits
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Developing a 10-Minute MRI Protocol to Improve Heart Disease Diagnosis and Care
Study of Surgical Outcomes and Quality Control for Complex Congenital Heart Disease Across All Ages in China
A Nationwide Study on Congenital Heart Disease Across All Life Stages in Chinese Patients
Feasibility Study of an 8-Week Parent-Child Yoga Program to Improve Attention in Children Aged 4 to 6 with Congenital Heart Disease
Study of Invasive Hemodynamic Cardiopulmonary Exercise Testing in Adults with Congenital Heart Disease Undergoing Cardiac Catheterization
Study of Invasive Hemodynamic Measures in Adults for the Mayo Clinic Adult Congenital Heart Disease Registry
International Registry Evaluating Sodium-Glucose Cotransporter 2 Inhibitors SGLT2i in Adults with Congenital Heart Disease
Clinical Study of an Integrated Prenatal and Postnatal Treatment Model to Improve the Treatment Effect of Newborns With Critical Congenital Heart Disease
Study of Genetic and Environmental Factors in Pregnant Women With Fetuses Having Complex Congenital Heart Defects Using multiOMICS
Using a Clinical Decision Support System to Shorten Mechanical Ventilation After Heart Surgery in Children Under 12
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The effects of percutaneous branch pulmonary artery interventions in biventricular congenital heart disease: study protocol for a randomized controlled Dutch multicenter interventional trial.